Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study

BACKGROUND: Leucine-rich alpha-2-glycoprotein (LRG1) was found to be differentially expressed in sera from patients with Epithelial Ovarian Cancer (EOC). The aim of this study is to investigate the performance of LRG1 for detection of EOC, including early stage EOC, and to evaluate if LRG1 can compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing, Yin, Haidi, Zhu, Jianhui, Buckanovich, Ronald J., Thorpe, Jason D., Dai, Jianliang, Urban, Nicole, Lubman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370724/
https://www.ncbi.nlm.nih.gov/pubmed/25799488
http://dx.doi.org/10.1371/journal.pone.0121112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370724/
https://www.ncbi.nlm.nih.gov/pubmed/25799488
http://dx.doi.org/10.1371/journal.pone.0121112

Ejemplares similares